Overview
- Hologic, which closed its sale Tuesday, moved to private ownership under Blackstone and TPG.
- Shareholders received $76 per share in cash plus a non‑tradable right worth up to $3 based on Breast Health revenue in fiscal 2026 and 2027.
- Trading in HOLX ended with a Nasdaq delisting after the deal closed.
- Stephen MacMillan retired at closing and José “Joe” Almeida, a former Baxter and Covidien chief, became CEO.
- ADIA and GIC joined as minority investors as observers track the CVR revenue goals and the new owners set strategy for a business with about $4.1 billion in recent annual sales.